Citrix Systems Inc (CTXS) Fundamental Analysis & Valuation

NASDAQ:CTXSUS1773761002

Current stock price

103.9 USD
+0.04 (+0.04%)
At close:
103.93 USD
+0.03 (+0.03%)
After Hours:

This CTXS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CTXS Profitability Analysis

1.1 Basic Checks

  • In the past year CTXS was profitable.
CTXS Yearly Net Income VS EBIT VS OCF VS FCFCTXS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 200M 400M 600M 800M 1B

1.2 Ratios

Industry RankSector Rank
ROA 4.71%
ROE 40.08%
ROIC 9.05%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CTXS Yearly ROA, ROE, ROICCTXS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 100 200 300 400

1.3 Margins

Industry RankSector Rank
OM 14.43%
PM (TTM) 9.97%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CTXS Yearly Profit, Operating, Gross MarginsCTXS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 40 60 80

0

2. CTXS Health Analysis

2.1 Basic Checks

  • CTXS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for CTXS has been increased compared to 1 year ago.
  • The debt/assets ratio for CTXS is higher compared to a year ago.
CTXS Yearly Shares OutstandingCTXS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 50M 100M 150M
CTXS Yearly Total Debt VS Total AssetsCTXS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 2.89 indicates that CTXS is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • A Debt/Equity ratio of 3.92 is on the high side and indicates that CTXS has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 3.92
Debt/FCF N/A
Altman-Z 2.89
ROIC/WACC0.8
WACC11.34%
CTXS Yearly LT Debt VS Equity VS FCFCTXS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 1B 2B 3B

2.3 Liquidity

  • CTXS has a Current Ratio of 0.82. This is a bad value and indicates that CTXS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.81 indicates that CTXS may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.81
CTXS Yearly Current Assets VS Current LiabilitesCTXS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 1B 2B 3B

4

3. CTXS Growth Analysis

3.1 Past

  • CTXS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.00%.
  • CTXS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.08% yearly.
  • Looking at the last year, CTXS shows a small growth in Revenue. The Revenue has grown by 4.72% in the last year.
  • Measured over the past years, CTXS shows a small growth in Revenue. The Revenue has been growing by 3.29% on average per year.
EPS 1Y (TTM)4%
EPS 3Y-1.87%
EPS 5Y0.08%
EPS Q2Q%28.23%
Revenue 1Y (TTM)4.72%
Revenue growth 3Y2.66%
Revenue growth 5Y3.29%
Sales Q2Q%5.84%

3.2 Future

  • Based on estimates for the next years, CTXS will show a small growth in Earnings Per Share. The EPS will grow by 4.00% on average per year.
  • CTXS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.91% yearly.
EPS Next Y7.65%
EPS Next 2Y5.63%
EPS Next 3Y4.95%
EPS Next 5Y4%
Revenue Next Year4.15%
Revenue Next 2Y2.56%
Revenue Next 3Y3.45%
Revenue Next 5Y2.91%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CTXS Yearly Revenue VS EstimatesCTXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
CTXS Yearly EPS VS EstimatesCTXS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

1

4. CTXS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.16 indicates a rather expensive valuation of CTXS.
  • CTXS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.21.
  • Based on the Price/Forward Earnings ratio of 17.47, the valuation of CTXS can be described as rather expensive.
  • CTXS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.10.
Industry RankSector Rank
PE 18.16
Fwd PE 17.47
CTXS Price Earnings VS Forward Price EarningsCTXS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.86
CTXS Per share dataCTXS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.38
PEG (5Y)241.49
EPS Next 2Y5.63%
EPS Next 3Y4.95%

0

5. CTXS Dividend Analysis

5.1 Amount

  • No dividends for CTXS!.
Industry RankSector Rank
Dividend Yield N/A

CTXS Fundamentals: All Metrics, Ratios and Statistics

Citrix Systems Inc

NASDAQ:CTXS (9/29/2022, 8:17:34 PM)

After market: 103.93 +0.03 (+0.03%)

103.9

+0.04 (+0.04%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-26
Earnings (Next)11-03
Inst Owners0%
Inst Owner Change0%
Ins Owners7.14%
Ins Owner Change0%
Market Cap13.18B
Revenue(TTM)3.31B
Net Income(TTM)330.37M
Analysts77.78
Price Target106.08 (2.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.48
Dividend Growth(5Y)61.71%
DP27.94%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.16
Fwd PE 17.47
P/S 3.98
P/FCF N/A
P/OCF N/A
P/B 15.99
P/tB N/A
EV/EBITDA 19.86
EPS(TTM)5.72
EY5.51%
EPS(NY)5.95
Fwd EY5.72%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS26.12
BVpS6.5
TBVpSN/A
PEG (NY)2.38
PEG (5Y)241.49
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 40.08%
ROCE N/A
ROIC 9.05%
ROICexc N/A
ROICexgc 61.4%
OM 14.43%
PM (TTM) 9.97%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 3.92
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.81
Altman-Z 2.89
F-Score6
WACC11.34%
ROIC/WACC0.8
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4%
EPS 3Y-1.87%
EPS 5Y0.08%
EPS Q2Q%28.23%
EPS Next Y7.65%
EPS Next 2Y5.63%
EPS Next 3Y4.95%
EPS Next 5Y4%
Revenue 1Y (TTM)4.72%
Revenue growth 3Y2.66%
Revenue growth 5Y3.29%
Sales Q2Q%5.84%
Revenue Next Year4.15%
Revenue Next 2Y2.56%
Revenue Next 3Y3.45%
Revenue Next 5Y2.91%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Citrix Systems Inc / CTXS Fundamental Analysis FAQ

What is the fundamental rating for CTXS stock?

ChartMill assigns a fundamental rating of 4 / 10 to CTXS.


What is the valuation status for CTXS stock?

ChartMill assigns a valuation rating of 2 / 10 to Citrix Systems Inc (CTXS). This can be considered as Overvalued.


How profitable is Citrix Systems Inc (CTXS) stock?

Citrix Systems Inc (CTXS) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for CTXS stock?

The Price/Earnings (PE) ratio for Citrix Systems Inc (CTXS) is 18.16 and the Price/Book (PB) ratio is 15.99.


Is the dividend of Citrix Systems Inc sustainable?

The dividend rating of Citrix Systems Inc (CTXS) is 0 / 10 and the dividend payout ratio is 27.94%.